Craig Gutierrez

Craig Gutierrez is a seasoned scientist currently serving as a Senior Research Scientist at Iambic Therapeutics since April 2022, following a tenure as Research Scientist II. Prior experience includes a position as Research Scientist at ActivX Biosciences from January 2021 to February 2022, where Craig Gutierrez contributed to the application of MS-cleavable cross-linking mass spectrometry and the development of a GTPase targeting platform, as well as conducting phosphoproteomic analyses. Craig Gutierrez holds a Doctor of Philosophy degree in Mass Spectrometry from the University of California, Irvine - College of Medicine, completed between 2014 and 2020.